2025 HCPCS Code G9017
Amantadine hydrochloride, oral, per 100 mg (for use in a medicare-approved demonstration project)
TAGS: amantadine demonstration| Notice | HCPCS G9017 terminated on December 31, 2019. |
| Short Description | Amantadine hcl 100mg oral |
| HCPCS Action Code | N - No maintenance for this code |
| HCPCS Coverage Code | C - Carrier judgment |
| HCPCS Code Added Date | December 01, 2004 |
| HCPCS Action Effective Date | January 01, 2020 |
| HCPCS Pricing Indicator Code | 13 - Price established by carriers (e.G., not otherwise classified, individual determination, carrier discretion) |
| HCPCS Type Of Service Code | 1 - Medical care |
| HCPCS Multiple Pricing Indicator Code | A - Not applicable as HCPCS priced under one methodology |
| HCPCS Anesthesia Base Unit Quantity | 0 |
| HCPCS Coverage Issues Manual Reference Section Number |
Check Similar HCPCS Codes
- G9002 - Mccd,maintenance rate
- G9003 - Mccd, risk adj hi, initial
- G9004 - Mccd, risk adj lo, initial
- G9005 - Mccd, risk adj, maintenance
- G9006 - Mccd, home monitoring
- G9007 - Mccd, sch team conf
- G9008 - Mccd,phys coor-care ovrsght
- G9009 - Mccd, risk adj, level 3
- G9010 - Mccd, risk adj, level 4
- G9011 - Mccd, risk adj, level 5
- G9012 - Other specified case mgmt
- G9013 - Esrd demo bundle level i
- G9014 - Esrd demo bundle-level ii
- G9016 - Demo-smoking cessation coun
- G9017 - Amantadine hcl 100mg oral
- G9018 - Zanamivir,inhalation pwd 10m
- G9019 - Oseltamivir phosphate 75mg
- G9020 - Rimantadine hcl 100mg oral
- G9033 - Amantadine hcl oral brand
- G9034 - Zanamivir, inh pwdr, brand